Another example of the shift of pro-survival pathways activation was described when inhibition of Notch1 with different GSIs led to transient activation of ERK 1/2 signaling that made the Notch1-positive subpopulation of colon cancer cells more susceptible to cisplatin-induced cell death [428]. This evidence concerns the gene NOTCH1 and malignant colon neoplasm.